glp-1 retatrutide vs Tirzepatide (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness Why Retatrutide is different 👇

Morgan Global Research, 29 Nov

In the LEADER (liraglutide) and SUSTAIN-6 (semaglutide) trials [2, 3], the GLP-1RAs rapidly and greatly decreased HbA 1c levels compared to placebo, which may have partly contributed to the increased incidence of diabetic retinopathy complications observed in SUSTAIN-6 (HR: 1.76 [95% CI 1.11, 2.78])

They serve as an adjunct tool to support continued appetite control and metabolic health in the long term

Psychological Medicine 48(11):1749-1758

After a washout period of at least 3 weeks, patients received the complementary intervention

it targets both the GLP-1 and the GIP (glucose-dependent insulinotropic polypeptide) receptors